Author: Media OutReach Newswire

  • Vesalius Longevity Labs Appoints Harvey Spevak as Chairman to Accelerate Global Growth and Brand Development

    Vesalius Longevity Labs Appoints Harvey Spevak as Chairman to Accelerate Global Growth and Brand Development

    Appointment Follows US$6.5 Million Strategic Financing and Strengthens Board Leadership Alongside David Adelman, Kevin Mayer, Lee Applbaum and James McRoberts

    Vancouver, British Columbia and Scottsdale, Arizona – Newsfile Corp. – November 13, 2026 – Vesalius Longevity Labs Inc. (CSE: VLAB)(“Vesalius” or the “Company“), a leading global peptide and longevity company, today announced the appointment of Harvey Spevak, as Chairman of its Board of Directors, effective November 13, 2026. The appointment follows a US$6.5 million financing led by Mr. Spevak, who brings a globally recognized leader in the wellness space to Vesalius as interest in longevity and proactive health continues to accelerate.

    Mr. Spevak is an investor, a visionary leader in global wellness, lifestyle and hospitality, and Chairman of Equinox Group. With more than three decades of experience building and scaling iconic consumer brands, he is recognized for his brand-focused, consumer-centric approach to innovation, growth and long-term value creation. As Chairman, he will help guide Vesalius’ strategic direction, brand development and global expansion at the intersection of healthcare delivery and longevity science.

    Vesalius supplies peptide products to a significant network of healthcare providers across key global markets supporting their practices with product fulfillment and provider education. Continuing to scale its provider-led platform globally, the Company enters this next phase with momentum as the broader peptide therapeutics market is projected to reach US$295 billion by 2033, up from US$141 billion in 2025, according to Grand View Research.

    Recently, the Company announced an exclusive manufacturing partnership with FDA- registered Celularity (Nasdaq: CELU) at their Florham Park, New Jersey facility. Celularity operates a cGMP, Grade D/ISO 8, AABB certified manufacturing facility. The Company has now established an active, first-of-its-kind, U.S. “Made-in-the-USA” peptide manufacturing for its Peptual®-branded APIs (excluding any GLP type products).

    “I believe longevity represents one of the most exciting opportunities in health and wellness over the coming decade,” said Harvey Spevak, Chairman of Vesalius. “Vesalius has an ambitious vision for building a differentiated global platform. I’m excited to work with the Board and management team, bringing my experience in building consumer-focused brands, driving innovation and creating long-term value to help shape the company’s next phase of growth.”

    Mr. Spevak joins fellow board members with expertise in health, finance, media and global consumer businesses including: David Adelman, Co-Owner of the Philadelphia 76ers and New Jersey Devils; Kevin Mayer, Executive Chairman and Founder of Smash Capital, Co-CEO of Candle Media and former CEO of TikTok, who led Disney+, Hulu and ESPN+ at The Walt Disney Company; Lee Applbaum, Chief Marketing Officer of Norwegian Cruise Line and former Global CMO of Patrón Spirits; Dr. Kevin Serre, PhD, formerly the Head of Performance for the Canadian Department of Defense (DoD) Special Forces under CANSOFCOM, and James McRoberts, founder of the Company & Executive Chairman of MuseCell Innovations PTE LTD.

    “On behalf of the Board, I am pleased to welcome Harvey as Chairman,” said David Adelman, Director of Vesalius. “He joins a group of directors whose experience across health, finance, media and consumer brands has already helped shape Vesalius into the company it is today. With Harvey leading the Board, we are well positioned as Vesalius scales globally.”

    “Vesalius is well positioned to help shape the future of peptides and longevity, with high-quality products, a growing provider network and significant opportunity to scale,” said Kevin Mayer, Director of Vesalius. “Our ambition is to build a category-defining brand that earns the trust of providers and patients alike. I have known Harvey for many years, his leadership and strategic vision are exceptionally strong. Harvey has a proven track record of building an iconic brand and transforming an industry, and his leadership will be invaluable as we realize Vesalius’ full potential.”

    Financial Advisor

    Roth Capital Partners serves as the exclusive financial advisor to Vesalius Longevity Labs.

    About Vesalius
    Vesalius Longevity Labs (CSE: VLAB) is a longevity and regenerative health platform focused on peptides, biologics and preventative healthcare. Vesalius’ proprietary ecosystem is designed to connect healthcare providers with trusted, compliant pharmacies and support the people they serve with access to quality therapies, education, and partnerships.

    Through its announced collaboration with Celularity, the Company is developing a U.S. final-stage manufacturing and supply platform for its Peptual®-branded peptide APIs (active pharmaceutical ingredients) for domestic and international compounding supply chains in accordance with local laws and regulations. Vesalius’s vision is to deliver on the promise of longevity by enabling the future of personalized health and wellness.

    Investors interested in learning more about Vesalius Longevity Labs are encouraged to contact the Company at: https://www.vesaliuslabs.com/

    For further information, please refer to the Company’s disclosure record on SEDAR+ at www.sedarplus.ca.

    Investor contact:
    Julia Becker
    Vice President, Capital Markets
    +1(604) 785-0850
    jbecker@vesaliuslabs.com

    Media contact: Jack Taylor Worldwide, vesalius@jacktaylorpr.com

    The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release.

    FORWARD-LOOKING INFORMATION

    This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation, including, without limitation, statements relating to: the Company’s global expansion plans and growth objectives; the advancement of Vesalius’ healthcare provider platform in the longevity space; the anticipated benefits of Harvey Spevak’s appointment as Chairman and his expected contributions to the Company’s growth and brand-building strategy; the Company’s intention to leverage Mr. Spevak’s expertise in scaling premium wellness experiences; the scaling of the Company’s provider-led platform globally; the projected growth of the broader peptide therapeutics market, including projected market size of US$295 billion by 2033; the anticipated benefits of the exclusive manufacturing partnership with Celularity, Inc., including the development of a dedicated U.S. final stage API manufacturing and supply platform for the Company’s Peptual®-branded APIs; the advancement and commercialization of the Company’s Peptual®-branded peptide APIs; the Company’s ambition to build a category-defining brand that earns the trust of providers and patients; and the Company’s ability to shape the future of peptides and longevity.

    Forward-looking information is based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. Forward-looking information involves known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such risks and uncertainties include, but are not limited to: the ability of the Company to successfully execute its global expansion strategy; the ability to retain and attract key personnel, including the anticipated contributions of Mr. Spevak; the ability of the Company to grow its healthcare provider network domestically and internationally; risks associated with the manufacturing partnership with Celularity, Inc., including regulatory approvals and manufacturing timelines; the ability of the Company to successfully develop and commercialize its Peptual®-branded APIs to cGMP standards; risks inherent in the biotechnology, pharmaceutical and wellness industries, including regulatory and competitive risks; the actual size and growth rate of the peptide therapeutics market differing materially from third-party projections; the Company’s ability to raise sufficient capital to fund its operations and growth plans; general economic and market conditions; and other risks described from time to time in the Company’s filings made available on SEDAR+ at www.sedarplus.ca.

    Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on forward-looking information. The forward-looking information contained in this press release is expressly qualified in its entirety by this cautionary statement. The forward-looking information contained herein is made as of the date of this press release, and the Company does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.

    The issuer is solely responsible for the content of this announcement.

  • Bora Group 3Q26: Revenue and Net Income Expansion Continues U.S. Manufacturing and Biologics Footprint Complete; Margin Expansion to Follow as Utilization Improves

    Bora Group 3Q26: Revenue and Net Income Expansion Continues U.S. Manufacturing and Biologics Footprint Complete; Margin Expansion to Follow as Utilization Improves

    HONG KONG SAR – Media OutReach Newswire – 13 November 2026 – Bora Pharmaceuticals (“Bora”; TWSE: 6472; OTCQX: BORAY) today announced its financial results and operational highlights for 3Q2026 and provides 2027 outlook update.

    3Q26 Business and Financial Highlights
    • Record quarterly revenue of NT$6,453 million, up 9.6% QoQ; basic EPS of NT$4.79, up 9.9% QoQ. Building on 2Q26 momentum, revenue increased by NT$564 million QoQ and operating income by NT$104 million. Excluding one-time M&A-related costs in both quarters, operating income would have increased approximately NT$ 140mn QoQ.
    • Year-to-date, CDMO wins span across controlled substances, complex oral solids, high potency products, sterile ophthalmic and biologics across U.S., Canadian and Taiwan sites; investments of the past few years are expected to contribute to profitability from 2H27.
    • Near term, CDMO 12-month rolling backlog reached US$340 million as of end-3Q26. Backlog build partly reflects the timing of conversion at the Maryland injectables site, where quality and technical platform upgrades are underway ahead of scaled production and a semi-annual maintenance shutdown in September.
    • Pharma sales revenues rose 12.5% QoQ and 9.3% YoY. Specialty and brand franchises grew 22.4% over 2025 average quarterly run rate and market leadership of DLS and other leading generics sustained. With growth momentum restored, the pharma sales business firmly anchors the Group’s revenue and earnings as CDMO enters its accelerated growth phase.
    • Share capital increased 0.3% during the quarter from employee stock option exercise.
    Mr. Bobby Sheng, Chairman of Bora Group, stated, “In 2026, customers are choosing Bora because we combine onshore North American capacity with capabilities rarely found in a network of our size. Our focus now is execution: completing these commercial technology transfers in our US facilities on time, qualifying our new isolator fill-finish capacity, where 4 PPQ batches have been completed and 3 additional technology transfer programs are scheduled for 2027, and delivering on every quality commitment we have made.

    “The acquisitions we completed between 2024 and 2026, supported by US$55 million in cumulative capital investment, more than 50% of it in specialized onshore capabilities, have broadened our offering and are now converting into wins, which we expect to translate into commercial revenue over the next 3 to 5 years. Near term, elevated financing costs continue to weigh on net profit, and sites still ramping toward full utilization are affecting our gross margin mix. We are now in the final stretch of this investment cycle.

    Year-to-date CDMO wins reached an exceptional all-time high of US$437 million, driven predominantly by multi-year commercial agreements and a deepening pre-commercial portfolio. These programs are expected to bring 24 new molecules into the Bora network, including 5 novel molecules across preclinical to registration, adding to the approximately 110 molecules we manufacture or process each quarter. Together, they extend our visibility from a 12-month backlog of US$340 million to more than 5 years of recurring commercial supply, supported by a pipeline of client programs that includes first-in-class therapies and treatments for diseases with no approved options.

    Building on this momentum, we delivered both sequential and year-over-year growth at the operating level in the quarter, even as recently acquired and expanded sites are ramping toward full utilization and profitability. I am also encouraged by the team’s diligence in financial management as our CDMO business enters a new phase. Since last year, we have refocused our Pharma Sales strategy on defending and maximizing leading products, leveraging our strong manufacturing capability, and streamlining smaller products that tied up working capital. As a result, net working capital as a percentage of revenue reached its lowest level since the integration of Upsher-Smith, keeping Bora Group well positioned through periods of global currency and liquidity volatility.

    The Group will operate under one financial discipline with shared capabilities. To move from design to delivery, we established a group-wide procurement function and a CDMO manufacturing science and technology (MSAT) team in 2026. As we complete this investment cycle, we expect these synergies to surface in margin.”

    3Q26 Operational Achievements & 2027 Outlook
    Global CDMO Operations
    CDMO revenue, including internal orders, rose 14.9% YoY, driven by both organic and acquisition-led scale expansion, and eased 0.5% QoQ, reflecting production timing at the Maryland injectables site during its quality and technical platform upgrades. External CDMO revenue reached NT$2,085 million, up 16.9% YoY and down 1.5% QoQ. Notably, Bora manufactured 0.44 billion doses during the quarter. External orders have now backfilled the internal volume released as the Group streamlined smaller, highly competitive generics in 2025, restoring network utilization to healthier levels.

    Looking into 4Q26 and 2027, the Company is excited to see how biologics demand is shifting in our favor as sponsors are choosing partners on speed and risk mitigation. Capital is flowing to clinical-stage assets with a clear path to market, and biotech business models are evolving, with sponsors retaining their programs deeper into the clinic and through approval and commercialization and hence greater outsourcing needs. Simultaneously, rare-disease, immunotherapy and personalized medicines need lower volumes, yet commercially compliant cGMP capacity at that scale remains scarce. The orphan drug CDMO market alone is projected to more than double, from USD 15.2 billion in 2025 to USD 32.4 billion by 2035, with North America the largest market and Asia-Pacific the fastest growing, according to Spherical Insights, which names Bora Group among the top CDMO companies in the space.

    We are realigning our biologics assets to capture this demand. Rockville, which joined the Group in July, brings cell line development, R&D and process development laboratory capabilities alongside late-stage and commercial manufacturing, connecting Tanvex’s Zhubei and San Diego sites into a tri-site network servicing small and mid-sized biotechs. Programs can now move from early development to commercial supply without leaving the network. The realignment also reflects slower-than-planned uptake of new capacity in San Diego, and we expect it to be completed within the next 2 quarters.

    Pharma Sales Operations

    Revenue increased by 9.3% year-over-year and 12.5% quarter-over-quarter, arriving at NT$3,302 million in 3Q26, the first quarter of growth on both measures since the beginning of 2025. Revenue included a one-time licensing income from Megestrol Acetate ex-China.

    Specialty and brand products reached 47.0% of Pharma Sales revenue, with revenue 22.4% above the 2025 average quarterly run rate. The Vigabatrin franchise, our anchor rare-disease asset, continued to broaden patient access: formulary coverage exceeded our year-end goal in September, and inpatient channels are expanding. Incremental volume is supplied under the renegotiated supplier contracts, lifting the franchise’s economic contribution. Meanwhile, generics climbed back up as DLS reclaimed market leadership, narrowing the year-to-date impact of pricing.

    CHC Operations

    Sunway delivered its first full quarter at its new scale following the integration of Weider Global Nutrition. 3Q26 revenue of NT$1,063 million and operating income of NT$73 million each exceeded the full 1H26 total. As one-time acquisition costs wound down, the OPEX ratio fell to 35.2% from 38.2%, lifting operating margin to 6.9%. Year-to-date net income reached 22 times last year’s level, with core operations now generating most of pre-tax profit. Unlike the 2021 peak, today’s results rest on a more balanced end-market mix and a growing portfolio of own brands with direct channel access.

    Recent Investor Conference

    Bora will host English and Chinese online earnings call at 4:30 p.m. Taiwan time on Nov. 13th, 2026. The event will cover the Company’s 3Q26 financial and business results and 2027 outlook.

    🔗 Online Earnings Presentation and Replay Link: https://morganstanley.webcasts.com/starthere.jsp?ei=1781786&tp_key=5f9370f519

    Bora will participate in Jefferies London Healthcare Conference in November. For 1:1 meetings with management, please contact your Jefferies representative.

    Bora 2026 Earnings Schedule

    Q4 2026: Expected in the 2nd week of Mar 2027

    Disclaimer:

    This document and the accompanying information may contain forward-looking statements. All statements regarding the company’s future business operations, potential events, and prospects (including but not limited to forecasts, targets, estimates, and operational plans) are considered forward-looking statements unless they refer to factual occurrences. Forward-looking statements are subject to various factors and uncertainties that may cause significant differences from actual results, including but not limited to price fluctuations, actual demand, exchange rate variations, market share, competitive conditions, changes in the legal, financial, and regulatory framework, international economic and financial market conditions, political risks, cost estimates, and other risks and variables beyond the company’s control. These forward-looking statements are based on current predictions and assessments, and the company disclaims any responsibility for future updates.

    Hashtag: #BoraPharmaceuticals

    The issuer is solely responsible for the content of this announcement.

    About Bora

    Founded in 2007, Bora Pharmaceuticals (“Bora” or “the Company”, 6472.TW and BORAY.OTCQX) is a leading pharmaceutical services company with a vision and goal of “Contributing to Better Health All Over the World”. Operating under a “Dual Engine” model that integrates CDMO and commercial expertise, we empower pharmaceutical and biotech partners to optimize product development, accelerate launches, and scale supply to meet global patient needs. At the same time, we actively broaden R&D and sales infrastructure, focusing on niche and rare disease markets to improve patients’ quality of life.

    By investing in talent, infrastructure, and biologics expansion, Bora continues to transform operations and achieve sustainable growth. Committed to making success “certain,” Bora sets new standards in the pharmaceutical and CDMO industries.

    For more, please visit:

  • Chongqing: Forging New Connections Across Eurasia — Industry Matchmaking Conference of Chongqing Visit by Eurasian Enterprises Held

    Chongqing: Forging New Connections Across Eurasia — Industry Matchmaking Conference of Chongqing Visit by Eurasian Enterprises Held

    CHONGQING, CHINA – Media OutReach Newswire – 13 November 2026 – On November 12, the Industry Matchmaking Conference of Chongqing Visit by Eurasian Enterprises was held at Yuzhou Hotel. Around 700 representatives from businesses and institutions across Eurasia, along with government officials and business leaders from Chongqing, gathered to explore industrial partnerships and new opportunities for development.

    Under the theme “Chongqing: Forging New Connections Across Eurasia,” the event was jointly hosted by the Chongqing Municipal Commission of Economy and Information Technology and China CITIC Bank Chongqing Branch. It aimed to advance Chongqing’s “3+3+6+18” System of Modern Manufacturing Clusters by strengthening cooperation with Eurasian enterprises in advanced manufacturing. Leveraging the connectivity offered by the New International Land-Sea Trade Corridor and the Yuxinou (Chongqing–Xinjiang–Europe) international rail freight services, the event sought to attract Eurasian investment to Chongqing while helping local enterprises expand into overseas markets. Through this two-way approach, Chongqing aims to foster industrial growth, broaden market access, and create new opportunities for mutually beneficial cooperation.

    The conference opened with a video tracing the evolution of Chongqing’s industrial partnerships with Eurasian enterprises. What began with the inaugural visit of German Advanced Manufacturing Enterprises to Chongqing expanded into broader engagement of European Advanced Manufacturing Enterprises at the second edition and has now grown into a multifaceted partnership spanning Eurasia. Along the way, a series of signed projects have progressed to construction and operation, supported by coordinated efforts between central and local authorities and comprehensive services throughout the project lifecycle. From Germany to Europe and now across Eurasia, the expanding network of partnerships reflects the growing momentum of Chongqing’s international industrial cooperation.

    At the conference, Wang Zhijie, Secretary of the Leading Party Members Group and Director-General of the Chongqing Municipal Commission of Economy and Information Technology, presented Chongqing’s industrial strengths and development opportunities. His presentation highlighted four key advantages: a strong industrial foundation, a vast market, extensive transport connectivity, and a supportive business environment. Two opportunity lists were also released: Opportunity List for High-Quality Industrial Development in Chongqing and the Opportunity List for Application Scenarios in Chongqing. The former identified 180 investment opportunities with a combined investment value of RMB480 billion, while the latter presented 100 application scenarios open for cooperation. Together, the lists offered international businesses a clearer picture of Chongqing’s development priorities and potential areas for collaboration, inviting more Eurasian enterprises to explore opportunities within the city’s “3+3+6+18” System of Modern Manufacturing Clusters.

    The keynote session brought together prominent business leaders and industry experts, including Liu Yahuang, Member of the Standing Committee of the 14th National Committee of the Chinese People’s Political Consultative Conference and Chairman of Multinational (Holdings) Group; Pei Jinlin, Vice President of STMicroelectronics; Michael Heilig, Regional Representative of the German Association for Small and Medium-Sized Businesses (BVMW); Zhu Keping, Vice President for Asia-Pacific at Hellmann Worldwide Logistics; Wolfgang Ziebart, Founder of XYTE Mobility; and Savas Tumis, Founder and CEO of Tumis Industrial Management Consulting Co., Ltd. Drawing on their respective experience, the speakers offered fresh perspectives on strengthening industrial links between Chongqing and Eurasia.

    The conference also saw the launch of several new cooperation initiatives. The CITIC Goldstone Chongqing Fund for Specialized and Innovative Enterprises was announced, drawing on CITIC Goldstone’s investment expertise and project resources to support high-quality industrial development in Chongqing. The European Market Expansion & Localization Shared Services Center was also unveiled to help Chongqing enterprises strengthen their localized operations in European markets. A total of 28 cooperation projects, worth more than RMB20 billion, were signed during the conference. The launch of new service platforms and the signing of these agreements marked further progress in the deepening partnership between Chongqing and Eurasian enterprises, turning shared interests into tangible cooperation.

    As the only municipality directly under the central government in central and western China, Chongqing has been entrusted with two strategic positionings: a key strategic anchor for Large-Scale Western Development for a new era and a comprehensive hub for inland opening up. The city is also accelerating its development into a nationally important center for advanced manufacturing. The conference demonstrated how Chongqing is translating its advantages in international connectivity into opportunities for industrial cooperation. By leveraging the New International Land-Sea Trade Corridor and Yuxinou rail services, the city is attracting high-quality Eurasian enterprises to invest locally while supporting Chongqing manufacturers in expanding their presence across Eurasian markets. The combination of transport connectivity and industrial strengths is creating new momentum for development on both sides. Looking ahead, the Chongqing Municipal Commission of Economy and Information Technology will work closely with CITIC Group to capitalize on the city’s international transport links and establish regular platforms for cross-border industrial matchmaking. These efforts will deepen practical cooperation with Eurasian countries in advanced manufacturing, further upgrade Chongqing’s “3+3+6+18” System of Modern Manufacturing Clusters, and set a new example for inland opening up and international cooperation through stronger connectivity and shared development.

    Hashtag: #Chongqing

    The issuer is solely responsible for the content of this announcement.

  • Former Tencent Cloud AI Executive Eric Muqing Li Appointed Co-CEO of Education AI Company Qimingdaren

    Former Tencent Cloud AI Executive Eric Muqing Li Appointed Co-CEO of Education AI Company Qimingdaren

    CHENGDU, CHINA – Media OutReach Newswire – 13 November 2026 – According to a report by Leiphone, Eric Muqing Li, formerly Head of Global Business at Tencent Cloud AI, has recently been appointed Co-CEO of Qimingdaren, an AI-focused education technology company.

    1

    Eric Muqing Li received his bachelor’s and master’s degrees from Shanghai Jiao Tong University and was a visiting scholar at the University of California, Los Angeles (UCLA). In 2016, he joined YITU Technology, where he led the development of the company’s early AI industrialization framework and witnessed firsthand the rise of China’s “AI Four Little Dragons” from their startup beginnings to their peak.

    In 2018, Li joined Tencent YouTu Lab as Chief Solution Architect, where he was responsible for bringing computer vision technologies into practical applications. He subsequently served as Chief Architect and Deputy General Manager of Tencent Cloud Intelligence, before becoming Head of Global Business at Tencent Cloud AI.

    During his time at Tencent, he led teams in driving the real-world deployment of large models and other AI technologies across more than 20 industries. He also built the overseas business from the ground up, promoting the localization of AI products and solutions to better meet the needs of local markets.

    In September this year, Li officially left Tencent and subsequently joined Qimingdaren as Co-CEO.

    According to a veteran AI industry professional, Li, who was born around 1990, is one of the few young leaders in applied AI to have experienced the full arc of China’s AI industry: the peak years of the “AI Four Little Dragons,” the development of computer vision labs at major technology companies, the commercialization and deployment of large models, and the expansion into overseas markets.

    His appointment as Co-CEO of Qimingdaren may bring fresh perspectives and a distinctive approach to innovation in the education industry.

    Hashtag: #Qimingdaren

    The issuer is solely responsible for the content of this announcement.

  • From Message to Mandate: PRISM Summit 2026 Calls on Communicators to Claim Their Seat at the Governance Table

    From Message to Mandate: PRISM Summit 2026 Calls on Communicators to Claim Their Seat at the Governance Table

    Inaugural Singapore State of PR and Communications Survey unveiled as senior communicators, journalists and board leaders gather at METT Singapore

    SINGAPORE – Media OutReach Newswire – 13 November 2026 – PRISM Summit 2026, the flagship summit of the Institute of Public Relations of Singapore (IPRS), concluded on Thursday, 12 November 2026 at METT Singapore, bringing together 170 senior communications leaders, journalists, board directors and technology experts across the region. Held under the theme From Message to Mandate, the Summit examined how communications leaders can move beyond message delivery to influence organisational decisions, safeguard reputation and build stakeholder trust in an environment shaped by artificial intelligence, fragmented media and heightened scrutiny.

    Mr Tan Kiat How, Senior Minister of State for Digital Development and Information, delivering the Guest-of-Honour keynote
    Mr Tan Kiat How, Senior Minister of State for Digital Development and Information, delivering the Guest-of-Honour keynote

    Guest-of-Honour Mr Tan Kiat How, Senior Minister of State for Digital Development and Information, delivered the opening keynote, emphasising the critical role of communicators as trusted advisers to leadership, to help provide insight and judgement to guide better decisions and build organisational credibility. “The most valuable communication is not always the message that goes out. Sometimes it is the uncomfortable truth that gets brought in,” he said.

    (L to R) Jennifer Kok, Founder and CEO, Media OutReach Newswire; Mr Tan Kiat How, Senior Minister of State for Digital Development and Information; Cindy Lim, PRISM Summit 2026 Chair; and Ross Gan, President, Institute of Public Relations of Singapore (IPRS)
    (L to R) Jennifer Kok, Founder and CEO, Media OutReach Newswire; Mr Tan Kiat How, Senior Minister of State for Digital Development and Information; Cindy Lim, PRISM Summit 2026 Chair; and Ross Gan, President, Institute of Public Relations of Singapore (IPRS)

    Rosianna M. Silalahi, President Director of KompasTV, shared how standing for facts and editorial independence has kept Kompas Indonesia’s most trusted news brand despite mounting political and economic pressure, and urged PR professionals to build lasting relationships with trusted media rather than chase reach. “Reach is not necessarily trust. Virality is not credibility,” she said. Glenda Gloria, Co-Founder and Executive Editor of Rappler, said, “Technology may change how we communicate, but it should not change who we are or why we do what we do,” sharing how clarity of purpose became Rappler’s best defence against coordinated online attacks, and urged communicators to stay grounded in their values as technology reshapes the industry.

    The day closed with the unveiling of findings from the inaugural Singapore State of PR and Communications Survey, jointly conducted by Media OutReach Newswire and IPRS, which found that while 76% of practitioners have integrated AI into their workflows, only 15% feel in full control of their AI visibility.

    State of PR and Communications Survey

    Pamela Phua, Managing Partner, Southeast Asia, Media OutReach Newswire, presented highlights from the inaugural Singapore State of PR and Communications Survey, which captured how local practitioners view changing PR dynamics, an evolving media landscape, AI visibility and the use of AI tools in their daily workflows. Key findings include:

    • Earned media still sets the benchmark: 79% call earned coverage an important success indicator, even as 51% say the media landscape is shrinking and 48% say earned media is harder to secure.
    • AI visibility is redefining success: AI visibility and citations are emerging as key success indicators, and 72% recognise that press releases boost generative engine optimisation (GEO).
    • AI is freeing up time for strategy: 68% use AI most or all of the time, and strategic communications is rated the top competency for 2027 at 77%.

    “Tools, control and trust is why we are entering the golden age of PR,” she said. The full findings will be released later in the year.

    IPRS thanks its Title Sponsor Media OutReach Newswire; Silver and Coffee Sponsor Notified; Silver Sponsors Isentia and Truescope; Official PR Agency Pinpoint PR; Venue Partner METT Singapore; Audience Engagement Partner Pigeonhole; Supporting Partners Edge Digital, the Public Relations and Communications Association (PRCA), World Communication Forum Association (WCFA), Davos Communications Summit & Awards, Asia Pacific PR Network (APRN), Singapore Institute of Directors (SID) and Singapore Press Club (SPC); Media Partners Humas Indonesia and PR Indonesia; and all speakers and delegates for their contributions to PRISM Summit 2026.

    Notes to Editors
    1. High-resolution images from PRISM Summit 2026 are available for download here. Kindly credit: IPRS

    2. The full Singapore State of PR and Communications Survey findings will be released later in the year and shared with the media upon release.

    3. The full agenda and speaker list are available on the Summit website.

    4. Interview requests with IPRS leadership or Summit speakers can be arranged through the media contacts below.

    Hashtag: #PRISM2026 #IPRS #FromMessageToMandate #PublicRelations #StrategicCommunications


    The issuer is solely responsible for the content of this announcement.

    About the Institute of Public Relations of Singapore

    The Institute of Public Relations of Singapore represents public relations and communications practitioners in Singapore and promotes professional standards, continuing development and the advancement of the profession.

  • LOCUS-T and My Starfish Foundation Launch Illustrated Cancer Book to Make Cancer Information More Accessible

    LOCUS-T and My Starfish Foundation Launch Illustrated Cancer Book to Make Cancer Information More Accessible

    SHAH ALAM, MALAYSIA – Media OutReach Newswire – 13 November 2026 – Malaysian digital marketing agency LOCUS-T has joined hands with My Starfish Foundation (MSF) to launch What Do We Do Next? – Navigating Cancer With You, an illustrated book aimed at making cancer-related information easier to understand and more accessible to patients, families, caregivers and the wider community.

    The book launch and the United for Good Network (UGN) – Cancer Group Memorandum of Understanding (MoU) signing ceremony were both key highlights of the event held at KHIND Event Hall, Bukit Jelutong, Shah Alam, bringing together cancer-related non-governmental organisations (NGOs), healthcare professionals and community partners to strengthen cancer awareness and support in Malaysia.

    Developed as a joint corporate social responsibility (CSR) initiative between LOCUS-T and My Starfish Foundation, the publication seeks to address a common challenge in cancer education: making complex medical information understandable, particularly for individuals who may find conventional, text-heavy health resources difficult to navigate.

    Written and illustrated by Malaysian author Lee Yun Yann, the book uses illustrations and straightforward explanations to help readers better understand cancer, explore available options, identify relevant support and navigate the uncertainties that may follow a diagnosis.

    The book is available in a bilingual Chinese-English edition and a Bahasa Malaysia edition, extending its accessibility to different segments of the Malaysian community. Readers can also download a free digital copy of the book through My Starfish Foundation’s official website, making cancer-related information more accessible to the public.

    The publication also benefited from contributions by Dr. Lim Kue Peng of Cancer Research Malaysia and Carol Ng Ji Yin, founder of the BELove Cancer Society, whose expertise helped strengthen its content.

    For LOCUS-T, the collaboration represents an extension of its long-standing relationship with My Starfish Foundation and its commitment to contributing beyond the digital marketing industry.

    According to Deric Wong, Managing Director of LOCUS-T, the initiative reflects the agency’s belief in the power of communication to connect people and make difficult subjects more approachable.

    “Sometimes, a different way of presenting it can make people stop, look and perhaps be a little more open to the conversation,” said Wong during the launch.

    Wong also highlighted LOCUS-T’s long-standing involvement with My Starfish Foundation, including its previous support for the Bald & Beautiful initiative, which saw LOCUS-T employees shaving their heads in solidarity with the cause. He described the relationship as one built on genuine personal connections rather than simply corporate sponsorship.

    As an agency specialising in helping businesses communicate, tell their stories and connect with audiences, LOCUS-T sees the publication as an opportunity to apply the same belief in meaningful communication to a cause that affects individuals and families across Malaysia.

    Speaking at the event, Cheng Ping Keat, Chairman of My Starfish Foundation, emphasised the importance of making cancer information more approachable while strengthening support for those affected by the disease.

    “Pictures can open a conversation when words feel difficult. They can make an unfamiliar subject more approachable, and help us see the person behind the illness,” he said.

    The book launch was officiated by Dr. Nur Aslina binti Bahakodin, Director of the National Cancer Institute, Ministry of Health Malaysia, who highlighted the importance of accurate, clear and accessible health information in helping patients and families understand their circumstances and make informed decisions with guidance from healthcare professionals.

    The voluntary collaborative network aims to bring together cancer-related NGOs to strengthen organisational capabilities, encourage knowledge and resource sharing, improve coordination and create greater collective impact for patients, survivors and caregivers.

    Representatives of participating cancer-related organisations signed the MoU, with Dr. Nur Aslina binti Bahakodin witnessing the signing, signifying a shared commitment to stronger collaboration within Malaysia’s cancer support ecosystem.

    The event also featured a sharing session titled “Early Detection and the Role of Communities” by Dato’ Dr. Saunthari Somasundaram, President of the National Cancer Society Malaysia (NCSM).

    Her session highlighted the importance of community participation in cancer awareness and early detection, particularly in addressing barriers to screening, ensuring timely follow-up and connecting individuals with appropriate care and support.

    For LOCUS-T, the initiative reinforces the importance of partnerships that create meaningful impact beyond business outcomes.

    Established in 2000, LOCUS-T has spent more than 26 years helping Malaysian businesses strengthen their digital presence through strategic communication, technology and innovation. Its involvement in the Cancer Illustration Book reflects the agency’s continued commitment to supporting initiatives that benefit the wider community.

    Through its collaboration with My Starfish Foundation, LOCUS-T hopes the book will serve not only as an accessible source of cancer-related information but also as a starting point for more open conversations among patients, families and communities.

    Wong also expressed hope that the launch would encourage more conversations about cancer, emphasising that meaningful impact can begin with something as simple as getting people to talk.Hashtag: #ThisIsLOCUST #ThriveTogether #MyStarfishFoundation




    The issuer is solely responsible for the content of this announcement.

    About LOCUS-T

    Established in 2000, LOCUS-T is a leading Malaysian digital marketing agency providing end-to-end digital growth solutions spanning Search Engine Optimization (SEO), Paid Advertising (Google, Meta, TikTok), website design and development, website maintenance and Xiaohongshu (RED) marketing.

    Having served more than 7,000 clients across over 50 industries, LOCUS-T combines strategic expertise with performance execution to help businesses strengthen online visibility, attract qualified customers and achieve measurable digital growth.

    LOCUS-T is a Google Premier Partner, Meta Business Partner and TikTok Gold Partner, reflecting its commitment to delivering trusted, results-driven digital marketing solutions. In 2025, the agency was also recognised by the Malaysia Book of Records for achieving the title of ““

    About My Starfish Foundation

    My Starfish Foundation (MSF) is a Malaysian charitable foundation that connects individuals, organisations and communities to create meaningful social impact.
    Guided by its vision, “Making a Difference, Together!”, the foundation focuses on uplifting communities, enhancing wellbeing and promoting arts and culture. Through partnerships and collaborative initiatives, MSF supports programmes that empower people, improve lives and create lasting positive change.

  • Yicura BioMed Advances Dual Capital and Industrial Strategy: Completes First Closing of Series B Financing Led by Gobi Partners

    Yicura BioMed Advances Dual Capital and Industrial Strategy: Completes First Closing of Series B Financing Led by Gobi Partners

    Advancing Core Product ICVAX® for HIV & Immunotherapy Pipeline for Cancers

    HONG KONG SAR – Media OutReach Newswire – 13 November 2026 – Yicura BioMed (“Yicura“), a clinical-stage immunotherapy company based in the Hong Kong Science Park developing medicines for infectious diseases, cancers, and inflammatory diseases, is pleased to announce today the first closing of its Series B financing led by Gobi Partners, with participation from a number of strategic investors from Wuxi and institutional investors from Hong Kong. Their participation reflects shared confidence in Yicura’s clinical development path. Proceeds will be deployed to advance the core product ICVAX® for HIV and to accelerate the development of the immunotherapy pipeline for cancers across the vaccine and antibody programmes.

    ICVAX® has completed a randomised, placebo-controlled NMPA-approved Phase I clinical trial in people living with HIV on antiretroviral therapy, with favourable safety and immunogenicity performance. The program is advancing to Phase II clinical trial for efficacy evaluation for a more durable immune control of HIV and the target path to functional cure.

    “This funding round marks an important step in Yicura’s growth as we move ICVAX® from early clinical validation towards efficacy studies,” Dr. Xia JIN, Co-Founder and CEO of Yicura, said. “We are encouraged by the Phase I data of ICVAX® and the potential of our PD-1-enhanced DNA vaccine and anti-∆42PD1 antibody platforms to address serious unmet needs in infectious diseases, cancers and inflammation. We are grateful for Gobi Partners’ partnership and the investors’ confidence in our science, our team and our mission to develop immunotherapies that can meaningfully change the standard of care for patients.”

    “Yicura is building a distinctive suite of immunotherapies from Hong Kong, with a clear clinical lead in ICVAX® and platform technologies that can extend well beyond a single indication to precision therapies for cancers.” Mr. Fred LI, Managing Director and Head of University Ventures of Gobi Partners, shared, “We are pleased to lead this Series B financing and to support Dr. JIN and the Yicura team as they advance the promising HIV therapeutic vaccine and continue to translate their brilliant technologies into medicines for patients in need.”

    Hashtag: #醫克生物 #Yicura


    The issuer is solely responsible for the content of this announcement.

    About Yicura BioMed (formerly known as Immuno Cure)

    Yicura BioMed (“Yicura”) is a clinical-stage biotechnology group based in the Hong Kong Science Park, focusing on research and development of immunotherapies for cancers, inflammations, and infectious diseases based on its patented PD-1-enhanced DNA vaccine and anti-Δ42PD1 antibody platforms.

    To learn more about Yicura, please visit:

    About Gobi Partners

    Founded in 2002, Gobi Partners is a leading pan-Asian investment firm specialising in bespoke capital solutions for family offices, sovereign wealth funds, financial institutions and corporate investors. Headquartered in Hong Kong and Kuala Lumpur, Gobi manages US$2 billion across 30+ investment vehicles, investing in early to growth-stage companies with the potential for generational and global impact.

    The firm’s team of over 90 investment professionals operates from 18 locations, curating a diversified portfolio of more than 400 companies, with 76 exits achieved to date. Gobi is recognised for its long-term, values-aligned approach, building ecosystems at the intersection of technology, sustainability, and inclusion. From pioneering TaqwaTech for two billion Muslims, to advancing the circular economy, to promoting gender-diverse leadership, Gobi backs the trends that are reshaping societies.

    Gobi’s edge lies in identifying structural and demographic shifts, forging partnerships with universities and institutions of higher education; bridging world-class research with private capital and bringing deep technology breakthroughs to commercialisation.

    Official Website:
    Official Linkedin:

  • L’OCCITANE Celebrates 50 Years Of Provençal Craftsmanship With Holiday 2026 Collection

    L’OCCITANE Celebrates 50 Years Of Provençal Craftsmanship With Holiday 2026 Collection

    Featuring a creative collaboration with artist Caroline Romain-Desfossés, the Maison marks its golden milestone with a festive collection inspired by the art of gifting.

    KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 13 November 2026 – Marking 50 years since its founding in 1976, L’OCCITANE en Provence celebrates five decades of Provençal craftsmanship, nature-inspired beauty, and creative expression with its Holiday 2026 collection, Craft the Surprise.
    Commemorating this golden milestone, the Maison brings together its heritage and contemporary artistic perspectives through creative collaborations with French artist Caroline Romain-Desfossés and renowned photographer Koto Bolofo. Together, their artistic contributions bring a distinctive visual identity to the holiday season, capturing the spirit of Provence and the artistry behind the Maison’s longstanding traditions.
    Centred on the theme of Craft the Surprise, the Holiday 2026 collection explores the meaning of thoughtful gifting through a selection of iconic beauty collections, seasonal fragrances, curated gift sets, and limited-edition creations. From everyday body care to indulgent skincare and home-fragrance rituals, the collection reflects L’OCCITANE’s approach to creating meaningful experiences through products inspired by nature.

    50 Years of Craft, Nature and Creativity
    Since 1976, L’OCCITANE has drawn inspiration from the landscapes, ingredients and traditions of Provence. Over the past five decades, the Maison has built its identity around the relationship between nature, craftsmanship and sensory experiences, bringing the character of southern France into its beauty and lifestyle collections.
    The 50th Anniversary celebration offers an opportunity to revisit these foundations while looking towards the future. For Holiday 2026, this heritage is expressed through the artistic interpretation of Caroline Romain-Desfossés, whose creative contribution adds a contemporary perspective to the Maison’s festive storytelling.
    Her collaboration brings an artistic dimension to the Holiday 2026 Advent Calendar, translating the spirit of Provençal festivities into a distinctive design. The collection combines artistic expression with the Maison’s established identity, reinforcing its continued appreciation for creativity and craftsmanship.

    Craft the Surprise: A Holiday Collection Inspired by the Art of Gifting
    For Holiday 2026, L’OCCITANE brings together its established product collections and seasonal creations, offering a range of gifting options across skincare, body care, hair care, fragrance and home.
    The selection features several of the Maison’s signature collections:

    Shea Butter – Everyday Nourishment
    Recognised for its nourishing properties, the Shea Butter collection features everyday hand and body care essentials. The iconic Shea Butter Hand Cream remains a key gifting option, complemented by smaller formats and curated sets.

    Almond – Sensory Body Care
    Inspired by the almond groves of Provence, the Almond collection combines distinctive fragrance with sensorial textures. Its range includes shower, body and moisturising products, offering complementary options for a complete body-care routine.

    Immortelle – Advanced Skincare
    Featuring the Maison’s signature Immortelle ingredient from Corsica, the skincare collection includes targeted formulas designed to support skin radiance and a comprehensive skincare routine. The Immortelle Power Duo brings together complementary products for those seeking a more dedicated skincare ritual.

    Hair Care – Everyday Care Rituals
    The hair-care selection features complementary cleansing and treatment products, including shampoo and Hair Treatment Serum pairings designed to support stronger, healthier-looking hair.

    Home Fragrance – Nuit en Pinède
    Extending the gifting selection beyond personal care, the limited-edition Nuit en Pinède collection introduces an aromatic home-fragrance experience inspired by the pine forests of Haute-Provence. Combining peppermint, Scots pine and woody musk, the collection includes a scented candle, diffuser, hand cream, soap and foaming hand wash.

    Limited-Edition Fragrances for Holiday 2026
    Alongside its signature collections, L’OCCITANE introduces two seasonal fragrance expressions for the holiday period.
    Veillée Pralinée captures the warmth of festive gatherings through notes of golden praline, sandalwood and comforting vanilla, creating a rich and inviting fragrance experience.
    Nuit en Pinède offers a fresher aromatic interpretation, inspired by the pine groves of Haute-Provence. Its combination of invigorating peppermint, resinous Scots pine and woody musk brings the atmosphere of the Provençal landscape into the home.
    Together, these seasonal collections reflect two distinct interpretations of the holiday season, from the warmth of festive gatherings to the freshness of nature.

    The Art of Gifting: Personalisation and Discovery in Malaysia
    In Malaysia, the Craft the Surprise campaign extends beyond the collection through an in-store gifting experience at KL Midtown, running from 5 November to 31 December 2026.
    The activation invites visitors to explore the Holiday 2026 collection, discover curated gifting recommendations and personalise selected gifts. The experience reflects L’OCCITANE’s emphasis on the personal nature of gifting, allowing customers to create thoughtful selections for different relationships and occasions.
    The collection is available across a range of price points, from smaller gifting options below RM100 to premium beauty sets and the Maison’s seasonal Advent Calendars.
    The Advent Calendar is available in Classic and Prestige editions, each featuring a curated selection of L’OCCITANE products behind its doors. Created in collaboration with artist Caroline Romain-Desfossés, the calendars combine artistic design with the experience of discovering the Maison’s beauty collections throughout the festive season.
    A Message from L’OCCITANE Malaysia

    Our approach to retail continues to focus on creating meaningful experiences that bring our brand and products closer to our customers. As we celebrate our 50th Anniversary, Holiday 2026 gives us an opportunity to bring together our heritage, creative collaborations, and intentional gifting experiences. Through Craft the Surprise, we hope to encourage customers to discover the collection, explore our signature products, and create more personal gifting moments – whether for themselves or the people who matter to them.”

    — Elida, General Manager, SEA

    As L’OCCITANE marks five decades of Provençal craftsmanship, Craft the Surprise reflects the Maison’s belief that gifting is an expression of thoughtfulness and connection. The Holiday 2026 collection brings this sentiment to life through the meeting of heritage, creativity and the enduring art of giving.

    EDITORIAL REFERENCE & MEDIA INFORMATION
    Holiday 2026: Selected Gift Sets and Recommended Retail Prices
    Price range
    Selected collections
    RRP
    Below RM100
    Hand of Provence Trio
    RM70
    Orchard Embrace
    RM85
    Limited Edition 30ml Hand Creams
    RM50
    RM100–RM199
    Provence Travel Essential
    RM110
    Holiday Crackers Kit
    RM150
    Nuit en Pinède Scented Candle 180g
    RM195
    RM200–RM299
    Happy Hands Collection
    RM240
    Nutty Nourishment Almond Set
    RM250
    Gentle Softness Shea Set
    RM275
    RM300–RM499
    Lasting Body Bliss
    RM440
    Almond Indulgence
    RM455
    Cleanse & Reset Skincare Duo
    RM480
    RM500 and above
    Classic Advent Calendar
    RM550
    Prestige Advent Calendar
    RM850
    The Classic Advent Calendar has a stated value of RM1,058, while the Prestige Advent Calendar has a stated value of RM1,516 and is limited to 200 pieces nationwide.

    Holiday 2026 Retail Activation
    Craft the Surprise in Malaysia – Gifting Pop-Up Experience
    • Venue: KL Midtown
    • Campaign period: 5 November – 31 December 2026
    • Experience: Holiday collection discovery, gifting recommendations and personalisation of selected gifts.
    Holiday 2026 E-Catalogue

    Hashtag: #LOccitaneMY #LOccitaneHoliday #CraftTheSurprise #Gifted


    TikTok :

    The issuer is solely responsible for the content of this announcement.

    L’Occitane Malaysia Sdn Bhd

    A Beauty Maison revealing the living force of flora since 1976, L’OCCITANE en Provence draws inspiration from the vibrant nature and cultures of Haute-Provence. The Maison creates skincare, body care, fragrance and home collections formulated in France with botanical ingredients and enhanced by advanced science and an environmentally conscious approach.

    Today, L’OCCITANE en Provence shares its philosophy through more than 3,000 boutiques worldwide, 100 spas, 2,500 partner hotels and its own destination hotel, Le Couvent des Minimes, un Hôtel & Spa L’OCCITANE en Provence.

  • Zoho Rebuilds Campaigns Platform With Simpler Email and SMS, Native WhatsApp and AI Agent Workflows

    Zoho Rebuilds Campaigns Platform With Simpler Email and SMS, Native WhatsApp and AI Agent Workflows

    • A rebuilt email editor and redesigned workspace cut the steps to create and launch a campaign
    • Email, SMS and WhatsApp now run from a single workflow
    • Model Context Protocol (MCP) support lets compatible AI agents build, schedule and analyze campaigns
    • Paid plans still start at $4 a month, with no price increase.

    SINGAPORE – Media OutReach Newswire – 13 November 2026 – Zoho Corporation, a global technology company, today announced a comprehensive update of Zoho Campaigns, its multichannel marketing platform. The update introduces a redesigned campaign experience, a template editor rebuilt from scratch, faster contact imports and email sends, native WhatsApp marketing, and support for AI agent workflows that can coordinate multi-step tasks through compatible AI tools.

    Together, these new features make everyday campaign work easier, from building an email and selecting an audience to coordinating messages across email, SMS and WhatsApp. Marketers can now create and manage campaigns with fewer steps, work with customer data across multiple channels, and use compatible AI agents to handle tasks ranging from campaign preparation to performance analysis.

    “Marketing tools should help marketers get campaigns out the door, not make them navigate unnecessary complexity,” said Gibu Mathew, Managing Director, Zoho APAC. “We rebuilt Zoho Campaigns to make campaign creation faster and simpler, with improved performance and unifying email, SMS and WhatsApp channels together into one experience. With Campaigns’ AI agent workflows, marketers can delegate multi-step tasks while retaining control over their campaigns and decisions, utilizing AI as a marketer’s assistant, not a replacement.”

    The rebuilt Zoho Campaigns platform improves the speed of key campaign operations.

    In Zoho internal testing, sending 100,000 emails is now up to four times faster than before, and importing 100,000 contacts is now up to five times faster.

    Despite these extensive updates, pricing for Zoho Campaigns remains the same, with paid plans starting at $4 a month.

    Additions to Zoho Campaigns include:

    • A simpler way to run multichannel campaigns
    • WhatsApp (New): Bulk campaigns using approved message templates, trigger-based messages, and WhatsApp steps inside automated workflows.
    • Email: Fewer setup steps, clear recipient counts, and streamlined A/B testing across subject line, sender and content.
    • SMS: Simplified gateway setup, including a streamlined 10DLC brand and campaign registration process for US senders.
    • Frequency capping: Limits how often a contact is messaged across all three channels, so a customer in an email campaign and an SMS campaign is not contacted twice in the same window.

    Connect compatible AI agents to campaign workflows

    Zoho Campaigns now supports the Model Context Protocol (MCP), an open standard that allows compatible AI agents to connect to supported application capabilities.

    Through supported integrations and configured permissions, marketers can use natural-language instructions to coordinate multi-step tasks in Zoho Campaigns. Rather than treating each action as a separate request, compatible agents can combine supported operations into a broader workflow.

    For example, a marketer can instruct a compatible agent to:

    • Prepare a seasonal campaign: Build a Black Friday campaign for an existing customer segment, use existing HTML content, send a test and schedule delivery.
    • Reuse successful campaigns: Analyze the last 10 campaigns, identify a strong performer, clone it and adapt the content for a new promotion.
    • Prepare a re-engagement campaign: Identify contacts who have not engaged in the last 90 days, create a re-engagement segment, tag the contacts and prepare a campaign.

    Depending on the connected agent, available capabilities and permissions, workflows can support campaign preparation, audience management, segmentation, performance analysis and other campaign operations.

    The goal is to extend AI beyond content generation into campaign execution and coordination. Marketers remain responsible for campaign decisions, with review and approval requirements determined by the configured workflow and permissions.

    AI-assisted content and more precise segmentation

    Zoho Campaigns also improves the tools marketers use to create content and define audiences, helping marketers combine more relevant content with more precise audience targeting, while reducing repetitive work:

    • Zia Content Analyzer: Built into the template editor, this AI assistant checks spelling, grammar and style in real time, suggests tone, clarity and phrasing improvements, and drafts subject lines, pre-headers and body copy for consistent email, SMS and WhatsApp campaigns.
    • Campaign Context: Apply a shared brief, including brand voice, offer details and audience information, across a defined set of campaigns to help maintain message consistency.
    • Advanced segmentation: Build audiences using layered criteria, engagement metrics and complex condition groups, with faster processing for large databases.

    A template editor redesigned for everyday marketing

    The new template editor is designed to help marketers create on-brand emails, adapt content for different devices and easy reuse designs across campaigns.

    Key improvements:

    • Themes: Define primary and secondary brand colors once and apply them consistently to linked template elements.
    • Dedicated mobile editing: Work in a separate mobile-design view to adjust layouts for smaller screens.
    • Dynamic content: Personalize individual content blocks for different audience segments within the same email.
    • Reusable content blocks and centralized styles: Save frequently used components and manage shared brand settings in one place.
    • Cleaner HTML output: Generate more streamlined email markup, supporting consistent rendering across email clients.

    Together, these changes reduce repetitive editing and help teams maintain consistent branding as they create and reuse campaigns.

    A better campaign workspace

    The rebuild also modernizes how marketers find and act on campaign data, reducing operational friction and helping marketers to move from campaign planning to execution more efficiently.

    • Redesigned workspace: A modernized interface with custom list views, advanced filtering and contextual information helps marketers find the data and actions they need.
    • Team collaboration: Shareable custom views and native contact tagging help teams organize and work with campaign data.

    Unified reporting across channels

    The updated reporting experience provides channel-level insights and a broader view of contact engagement, helping marketing teams connect campaign activity with contact engagement and business performance:

    • Channel dashboards: Access dedicated dashboards for email, SMS and WhatsApp, alongside a unified contact dashboard.
    • E-commerce integrations: Track ROI, revenue, orders and cart performance.
    • Zoho Analytics integration: Sync contact fields and campaign activity across email, SMS, WhatsApp and workflows for reporting in Zoho Analytics.
    • Unified contact scoring: View engagement across supported channels to understand contact activity in one place.
    • Centralized UTM management: Manage campaign tracking parameters more consistently.

    Closer integration with CRM and other systems

    Zoho Campaigns strengthens connections between marketing execution, customer data and external applications.

    • Live Zoho CRM sync: Keep contact data and audience segments up to date.
    • CRM custom views: Import contacts from a specific Zoho CRM custom view directly into a mailing list without recreating the filters.
    • Campaign creation from CRM data: Create campaigns using Zoho CRM data without switching between products for every step.
    • Expanded webhooks: Send campaign data to external applications to support connected workflows.

    These integrations help reduce manual data handling and keep marketing activity better aligned with customer information in connected systems.

    Pricing and availability

    The updated Zoho Campaigns is available now in all regions, with pricing unchanged.

    SMS and WhatsApp marketing capabilities are included at no additional platform charge; sending messages requires purchased credits.

    Zoho Campaigns continues to offer a free plan for up to 500 contacts and 2,000 emails per month.

    For more information, visit www.zoho.com/campaigns

    About Zoho Campaigns

    Zoho Campaigns is a multichannel marketing platform that helps businesses create, send and analyze email, SMS and WhatsApp campaigns. It integrates with Zoho CRM and Zoho Analytics and supports connected workflows for campaign execution and audience management.Hashtag: #Zoho

    The issuer is solely responsible for the content of this announcement.

    Zoho Corporation

    With 60+ apps in nearly every major business category, Zoho Corporation is one of the world’s most prolific technology companies. Zoho is privately held and profitable with more than 19,000 employees globally, with international headquarters in Chennai, India. Zoho APAC HQ is located in Singapore. Zoho respects user privacy and does not have an ad-revenue model in any part of its business, including its free products. The company owns and operates its data centers, ensuring complete oversight of customer data, privacy, and security. More than 150 million users worldwide rely on Zoho every day to run their businesses. For more information, please visit: www.zoho.com

  • EBANX and Eneba strengthen partnership in Latin America with 138% YoY growth in payment volume

    EBANX and Eneba strengthen partnership in Latin America with 138% YoY growth in payment volume

    With Pix, Nequi, and Mercado Pago among the most used payment methods by Eneba’s customers, the operation now covers eight countries in the region

    CURITIBA, BRAZIL – Media OutReach Newswire – 13 November 2026 – EBANX, a global technology company specializing in payment services for emerging markets, and Eneba, a Global digital marketplace for video games, have expanded their partnership across eight Latin American countries, building a payment portfolio around the local methods consumers use in each market.

    How local payments are driving growth for Eneba in LatAm
    How local payments are driving growth for Eneba in LatAm

    The partnership began in 2023 across Brazil, Mexico, Colombia, Chile, Peru, Ecuador and Bolivia, with Argentina added the following year. In 2026, the collaboration reached a new milestone: through October, Eneba’s processed volume through EBANX in Latin America grew 138% compared with the same period in 2025, more than doubling year over year.

    Since 2023, Eneba has expanded its payment offering in these markets by combining credit and debit cards with alternative payment methods (APMs), including digital wallets such as Mercado Pago and Colombia’s Nequi; instant payment systems such as Pix in Brazil and SPEI in Mexico; and cash-based methods such as Brazil’s Boleto Bancário, Mexico’s OXXO Pay, and Peru’s PagoEfectivo.

    “EBANX has been a strong partner in supporting our growth across Latin America. Their consistent performance and extensive coverage of local payment methods have helped us reflect consumer preferences in each market,” said Mantas Eitutis, Head of Payments and Fraud at Eneba.

    Local payments as a growth engine

    The growth comes as digital payments continue to expand in Latin America. Across the region, about 25% of adults own a credit card, while 51% have already made a digital payment, according to the World Bank. That figure has risen from 34% in ten years, underscoring the growing role of instant payments and digital wallets in online commerce.

    Eneba’s results in Latin America reflect that relevance. Throughout 2026, the company recorded consistent growth in transaction volumes across key local payment methods, including Pix in Brazil, Nequi in Colombia, and SPEI in Mexico.

    “There is no single payment playbook for Latin America. For global merchants, scaling across the region means understanding the differences and adapting the checkout to how consumers already pay,” said James Booth, VP Commercial at EBANX.
    Hashtag: #EBANX #Eneba #Gaming #LatAm #Payments

    The issuer is solely responsible for the content of this announcement.

    ABOUT EBANX

    EBANX is the leading payments platform connecting global businesses to the world’s fastest-growing digital markets. Founded in 2012 in Brazil, EBANX was built with a mission to expand access to international digital commerce. Leveraging proprietary technology, deep market expertise, and robust infrastructure, EBANX enables global companies to offer hundreds of local payment methods across Latin America, Africa, and Asia. More than just payments, EBANX drives growth, enhances sales, and delivers seamless purchase experiences for businesses and end-users alike.

    For further information, please visit:

    Website:
    LinkedIn:

    ABOUT ENEBA

    Eneba is a digital marketplace for video games that has served over 15 million buyers. Founded in 2018, Eneba has rapidly grown into a trusted ecosystem for gamers with game keys, gift cards, and mobile top-ups at the best prices, backed by robust customer support and fraud prevention measures.

    For further information, please visit:

    Website:
    LinkedIn: